AppliedLtd Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for AppliedLtd.
Wichtige Informationen
n/a
Wachstumsrate der Gewinne
n/a
EPS-Wachstumsrate
Specialty Retail Gewinnwachstum | 8.2% |
Wachstumsrate der Einnahmen | n/a |
Zukünftige Eigenkapitalrendite | n/a |
Analystenabdeckung | None |
Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Keine Aktualisierungen
Recent updates
There's No Escaping Applied Co.,Ltd.'s (TSE:3020) Muted Earnings
Aug 06AppliedLtd (TSE:3020) Is Posting Promising Earnings But The Good News Doesn’t Stop There
May 22Does AppliedLtd (TYO:3020) Have A Healthy Balance Sheet?
Apr 30Returns On Capital - An Important Metric For AppliedLtd (TYO:3020)
Mar 07Why Applied Co.,Ltd. (TYO:3020) Should Be In Your Dividend Portfolio
Feb 04We Think AppliedLtd (TYO:3020) Can Manage Its Debt With Ease
Jan 20AppliedLtd (TYO:3020) Has Gifted Shareholders With A Fantastic 141% Total Return On Their Investment
Jan 05Applied Co., Ltd.'s (TYO:3020) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 21Does Applied (TYO:3020) Have The DNA Of A Multi-Bagger?
Dec 06Applied's (TYO:3020) Earnings Are Growing But Is There More To The Story?
Nov 21In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da AppliedLtd jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.
Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.
Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
6/30/2024 | 43,211 | 1,286 | N/A | N/A | N/A |
3/31/2024 | 42,819 | 1,210 | 1,138 | 1,427 | N/A |
12/31/2023 | 42,466 | 1,352 | N/A | N/A | N/A |
9/30/2023 | 41,763 | 1,301 | 640 | 1,016 | N/A |
6/30/2023 | 39,954 | 1,230 | N/A | N/A | N/A |
3/31/2023 | 38,606 | 1,098 | 1,532 | 1,831 | N/A |
12/31/2022 | 39,987 | 1,071 | N/A | N/A | N/A |
9/30/2022 | 40,749 | 1,125 | 1,098 | 1,326 | N/A |
6/30/2022 | 43,045 | 1,256 | N/A | N/A | N/A |
3/31/2022 | 43,956 | 1,485 | 758 | 996 | N/A |
12/31/2021 | 40,983 | 1,619 | N/A | N/A | N/A |
9/30/2021 | 41,018 | 1,449 | 873 | 1,180 | N/A |
6/30/2021 | 40,106 | 1,419 | N/A | N/A | N/A |
3/31/2021 | 39,670 | 1,540 | 1,092 | 1,347 | N/A |
12/31/2020 | 38,041 | 1,294 | N/A | N/A | N/A |
9/30/2020 | 34,839 | 1,449 | 1,437 | 1,616 | N/A |
6/30/2020 | 33,636 | 1,456 | N/A | N/A | N/A |
3/31/2020 | 32,214 | 1,130 | 1,757 | 1,947 | N/A |
12/31/2019 | 32,013 | 1,375 | N/A | N/A | N/A |
9/30/2019 | 32,050 | 1,246 | 935 | 1,452 | N/A |
6/30/2019 | 30,804 | 1,120 | N/A | N/A | N/A |
3/31/2019 | 30,300 | 1,136 | 754 | 1,532 | N/A |
12/31/2018 | 29,672 | 940 | N/A | N/A | N/A |
9/30/2018 | 29,921 | 892 | 227 | 1,123 | N/A |
6/30/2018 | 30,304 | 801 | N/A | N/A | N/A |
3/31/2018 | 30,797 | 838 | N/A | 80 | N/A |
12/31/2017 | 30,656 | 622 | N/A | N/A | N/A |
9/30/2017 | 29,969 | 629 | N/A | -79 | N/A |
6/30/2017 | 29,682 | 650 | N/A | N/A | N/A |
3/31/2017 | 30,237 | 668 | N/A | -258 | N/A |
12/31/2016 | 31,116 | 713 | N/A | N/A | N/A |
9/30/2016 | 30,969 | 673 | N/A | 421 | N/A |
6/30/2016 | 29,753 | 739 | N/A | N/A | N/A |
3/31/2016 | 29,002 | 657 | N/A | 843 | N/A |
12/31/2015 | 28,518 | 512 | N/A | N/A | N/A |
9/30/2015 | 28,251 | 413 | N/A | N/A | N/A |
6/30/2015 | 27,681 | 168 | N/A | N/A | N/A |
3/31/2015 | 26,720 | 84 | N/A | -60 | N/A |
12/31/2014 | 27,054 | 167 | N/A | N/A | N/A |
9/30/2014 | 27,087 | 103 | N/A | 570 | N/A |
6/30/2014 | 27,643 | 139 | N/A | N/A | N/A |
3/31/2014 | 27,720 | 106 | N/A | 513 | N/A |
12/31/2013 | 26,315 | -2 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: Insufficient data to determine if 3020's forecast earnings growth is above the savings rate (0.3%).
Ertrag vs. Markt: Insufficient data to determine if 3020's earnings are forecast to grow faster than the JP market
Hohe Wachstumserträge: Insufficient data to determine if 3020's earnings are expected to grow significantly over the next 3 years.
Einnahmen vs. Markt: Insufficient data to determine if 3020's revenue is forecast to grow faster than the JP market.
Hohe Wachstumseinnahmen: Insufficient data to determine if 3020's revenue is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if 3020's Return on Equity is forecast to be high in 3 years time